🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Newly Diagnosed Acute Myeloid Leukemia With High Risk

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT00801489Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cytarabine, Decitabine, Filgrastim-sndz, Fludarabine Phosphate, Gemtuzumab Ozogamicin HVA vs IA/DA or VA in the Treatment of ND HR-AML NCT06810791Phase 31 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: HVA, VA, Standard Chemotherapy Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML. NCT06483906Phase 21 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Venetoclax, Azacitidine and Homoharringtonine Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia NCT03214562Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cytarabine, Filgrastim, Fludarabine, Idarubicin, Pegfilgrastim A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients NCT06928376Phase 21 site📍 Beijing Chinese PLA General Hospital · Tests: Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor, "3+7" Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML NCT04588922Phase 1, Phase 232 sites📍 Birmingham📍 Goodyear📍 Phoenix Sellas Life Sciences Group · Tests: SLS009, venetoclax, azacitidine ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT05010122Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Decitabine and Cedazuridine, Gilteritinib, Venetoclax Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT04047641Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cladribine, Cytarabine, Idarubicin, Quizartinib Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients NCT06394011Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: venetoclax, azacitidine and HAAG regimen Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML NCT07259707Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: GVA + HDAC Consolidation & Gilteritinib Maintenance Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer NCT07046078Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy,… High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) NCT07177079Phase 11 site📍 Iowa City Kittika Poonsombudlert · Tests: Azacitidine, Venetoclax, High-dose ascorbate, Decitabine Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial) NCT05554406Phase 2227 sites📍 Birmingham📍 Phoenix📍 Tucson National Cancer Institute (NCI) · Tests: Azacitidine, Biospecimen Collection, Bone Marrow Aspiration, Cytarabine, Daunorubicin Hydrochloride Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS NCT05342584Phase 11 site📍 The Bronx Montefiore Medical Center · Tests: Venetoclax Oral Tablet, Daunorubicin, Cytarabine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy